HK1224221A1 - 含有托格列淨的固體製劑及其生產方法 - Google Patents

含有托格列淨的固體製劑及其生產方法

Info

Publication number
HK1224221A1
HK1224221A1 HK16112651.7A HK16112651A HK1224221A1 HK 1224221 A1 HK1224221 A1 HK 1224221A1 HK 16112651 A HK16112651 A HK 16112651A HK 1224221 A1 HK1224221 A1 HK 1224221A1
Authority
HK
Hong Kong
Prior art keywords
tofogliflozin
solid preparation
producing same
producing
same
Prior art date
Application number
HK16112651.7A
Other languages
English (en)
Inventor
Kenta Wada
To-Moaki Hirayama
Kenichi Sakai
Shiho Yoshimura
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1224221A1 publication Critical patent/HK1224221A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16112651.7A 2013-12-27 2016-11-03 含有托格列淨的固體製劑及其生產方法 HK1224221A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013273060 2013-12-27
PCT/JP2014/084561 WO2015099139A1 (ja) 2013-12-27 2014-12-26 トホグリフロジンを含有する固形製剤及びその製造方法

Publications (1)

Publication Number Publication Date
HK1224221A1 true HK1224221A1 (zh) 2017-08-18

Family

ID=53478978

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16112651.7A HK1224221A1 (zh) 2013-12-27 2016-11-03 含有托格列淨的固體製劑及其生產方法

Country Status (22)

Country Link
US (2) US10231930B2 (zh)
EP (2) EP3087989B1 (zh)
JP (5) JP6513030B2 (zh)
KR (2) KR20210082557A (zh)
CN (2) CN113058038B (zh)
AU (1) AU2014370847B2 (zh)
BR (1) BR112016013164B1 (zh)
CA (1) CA2934832C (zh)
DK (1) DK3087989T3 (zh)
ES (1) ES2704065T3 (zh)
HK (1) HK1224221A1 (zh)
HR (1) HRP20182199T1 (zh)
HU (1) HUE041983T2 (zh)
LT (1) LT3087989T (zh)
MX (2) MX370342B (zh)
PL (1) PL3087989T3 (zh)
PT (1) PT3087989T (zh)
RU (1) RU2700164C2 (zh)
SI (1) SI3087989T1 (zh)
TR (1) TR201821042T4 (zh)
TW (2) TWI774159B (zh)
WO (1) WO2015099139A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2451018C2 (ru) 2006-04-07 2012-05-20 Вертекс Фармасьютикалз Инкорпорейтед Модуляторы атф-связывающих кассетных транспортеров
RU2700164C2 (ru) * 2013-12-27 2019-09-13 Чугаи Сейяку Кабусики Кайся Твердые препараты, содержащие тофоглифлозин, и способ их получения
CN108640958B (zh) * 2017-05-05 2021-03-30 镇江圣安医药有限公司 异苯并呋喃衍生物、其药物组合物和制剂以及用途
CN107811983A (zh) * 2017-12-04 2018-03-20 威海贯标信息科技有限公司 一种托格列净组合物
CN107759649A (zh) * 2017-12-12 2018-03-06 威海贯标信息科技有限公司 一种托格列净新晶型

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56145214A (en) 1980-04-11 1981-11-11 Taiho Yakuhin Kogyo Kk Ubidecarenone tablet
JP2626975B2 (ja) 1987-03-30 1997-07-02 エーザイ株式会社 低融点油性物質含有錠剤
ES2082723B1 (es) 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
JPH10287561A (ja) 1997-04-11 1998-10-27 Taisho Pharmaceut Co Ltd イブプロフェン配合固形製剤及びその製造方法
JP2000239185A (ja) 1999-02-16 2000-09-05 Taisho Pharmaceut Co Ltd 医薬組成物
EP1620111A4 (en) 2003-05-06 2012-03-21 Nirmal Mulye FORMULATION OF ERYTHROMYCIN DERIVATIVES WITH CONTROLLED RELEASE
JP2005104934A (ja) 2003-10-01 2005-04-21 Eisai Co Ltd 新規組成物及びその製造方法
JP4997741B2 (ja) 2004-11-12 2012-08-08 大正製薬株式会社 低融点薬物含有粉粒体及びその製造方法
TW200637869A (en) * 2005-01-28 2006-11-01 Chugai Pharmaceutical Co Ltd The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
PE20090185A1 (es) * 2007-03-22 2009-02-28 Bristol Myers Squibb Co Formulaciones farmaceuticas que contienen un inhibidor sglt2
JP4072195B2 (ja) 2007-10-18 2008-04-09 キッセイ薬品工業株式会社 速放性経口医薬組成物
TW201011043A (en) * 2008-06-20 2010-03-16 Chugai Pharmaceutical Co Ltd Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
KR101921934B1 (ko) * 2009-02-13 2018-11-26 베링거 인겔하임 인터내셔날 게엠베하 글루코피라노실 디페닐메탄 유도체를 포함하는 약제학적 조성물, 이들의 약제학적 용량형, 이들의 제조방법 및 환자에서의 개선된 당 조절을 위한 이들의 용도
US20130035281A1 (en) * 2011-02-09 2013-02-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
WO2012115249A1 (ja) 2011-02-25 2012-08-30 中外製薬株式会社 スピロケタール誘導体の結晶
AU2012264736A1 (en) * 2011-06-03 2013-11-28 Boehringer Ingelheim International Gmbh SGLT-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents
PT2981269T (pt) 2013-04-04 2023-10-10 Boehringer Ingelheim Vetmedica Gmbh Tratamento de distúrbios metabólicos em animais equinos
RU2700164C2 (ru) * 2013-12-27 2019-09-13 Чугаи Сейяку Кабусики Кайся Твердые препараты, содержащие тофоглифлозин, и способ их получения

Also Published As

Publication number Publication date
HRP20182199T1 (hr) 2019-02-22
PL3087989T3 (pl) 2019-07-31
SI3087989T1 (sl) 2019-03-29
US10398653B2 (en) 2019-09-03
US20190151248A1 (en) 2019-05-23
BR112016013164A2 (zh) 2017-08-08
AU2014370847A1 (en) 2016-06-16
RU2016130602A (ru) 2018-02-01
TW202126311A (zh) 2021-07-16
TWI774159B (zh) 2022-08-11
HUE041983T2 (hu) 2019-06-28
EP3087989A4 (en) 2017-09-20
EP3087989A1 (en) 2016-11-02
KR20160101719A (ko) 2016-08-25
TWI715523B (zh) 2021-01-11
CN105828826A (zh) 2016-08-03
RU2016130602A3 (zh) 2018-06-08
PT3087989T (pt) 2019-02-26
JP2022116267A (ja) 2022-08-09
JP2020203918A (ja) 2020-12-24
AU2014370847B2 (en) 2020-02-20
JPWO2015099139A1 (ja) 2017-03-23
CN113058038B (zh) 2024-01-12
CA2934832A1 (en) 2015-07-02
BR112016013164B1 (pt) 2022-07-26
RU2700164C2 (ru) 2019-09-13
CN105828826B (zh) 2021-04-06
KR20210082557A (ko) 2021-07-05
JP6513030B2 (ja) 2019-05-15
ES2704065T3 (es) 2019-03-14
US10231930B2 (en) 2019-03-19
JP2024063140A (ja) 2024-05-10
JP6759390B2 (ja) 2020-09-23
TW201609194A (zh) 2016-03-16
TR201821042T4 (tr) 2019-01-21
JP2019112424A (ja) 2019-07-11
WO2015099139A1 (ja) 2015-07-02
DK3087989T3 (en) 2019-03-25
EP3087989B1 (en) 2018-12-19
MX2016008527A (es) 2016-09-13
MX2019008865A (es) 2019-09-13
MX370342B (es) 2019-12-10
CN113058038A (zh) 2021-07-02
KR102395687B1 (ko) 2022-05-06
US20160324786A1 (en) 2016-11-10
EP3482748A1 (en) 2019-05-15
CA2934832C (en) 2022-03-15
LT3087989T (lt) 2019-02-11

Similar Documents

Publication Publication Date Title
HK1221720A1 (zh) 喹唑啉衍生物及其製備方法
EP3006415B8 (en) Method for producing nanocement and nanocement
HK1206755A1 (zh) 低酸性物種組合物及其生產和應用的方法
EP2945678A4 (en) PATIENT INTERFACE AND METHOD FOR MANUFACTURING THE SAME
EP2945680A4 (en) PATIENT INTERFACE AND METHOD FOR THE PRODUCTION THEREOF
EP2947416A4 (en) SENSOR AND METHOD FOR THE MANUFACTURE THEREOF
IL239949B (en) Docking component and method for its production
EP2949783A4 (en) LUBICLE ELEMENT AND METHOD FOR THE PRODUCTION THEREOF
IL244285A0 (en) Methods for preparing edible preparations and edible preparations so produced
SG11201509326TA (en) Ship-type structure and method for designing ship-type structure
SG11201602587TA (en) Method for producing instant noodles and instant noodles
EP3028722A4 (en) TREATMENT AGENT FOR CARTILAGE DAMAGE AND METHOD FOR THE PRODUCTION THEREOF
EP2944462A4 (en) LAMINATE AND METHOD FOR THE MANUFACTURE THEREOF
SG11201508747XA (en) Tissue structure and manufacturing method therefor
EP3006058A4 (en) BLOOD FILTER AND METHOD FOR THE PRODUCTION THEREOF
EP2937766A4 (en) CONDUCTIVE STRUCTURE AND MANUFACTURING METHOD THEREFOR
EP3040074A4 (en) PHARMACEUTICAL PREPARATION OF INJECTION, AND METHOD OF MANUFACTURING THE SAME
GB201305414D0 (en) Method and composition
HRP20182199T1 (hr) Kruti pripravci koji sadrže tofogliflozin i postupak za njihovu proizvodnju
EP2982843A4 (en) PROTECTIVE SCREEN AND METHOD FOR PRODUCING PROTECTIVE SCREEN
EP2979855A4 (en) LAMINATE AND METHOD FOR PRODUCING THE SAME
ZA201602129B (en) Audiometry system and method
EP3051131A4 (en) COMPRESSOR AND METHOD FOR PRODUCING A COMPRESSOR
IL246199A0 (en) Tampon and method for its preparation
PL3061867T3 (pl) Podsypka i sposób jej wytwarzania

Legal Events

Date Code Title Description
CORR Corrigendum

Free format text: HONG KONG INTELLECTUAL PROPERTY JOURNAL DATED 20.08.2021 CORRECTED DATA OF SECTION 27: (72) HIRAYAMA, TOMOAKI WADA, KENTA SAKAI, KENICHI YOSHIMURA, SHIHO